Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
21.81
+0.25 (1.16%)
Apr 14, 2026, 9:58 AM EDT - Market open
Tango Therapeutics Revenue
In the year 2025, Tango Therapeutics had annual revenue of $62.38M with 48.29% growth.
Revenue (ttm)
$62.38M
Revenue Growth
+48.29%
P/S Ratio
49.31
Revenue / Employee
$455,358
Employees
137
Market Cap
3.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.38M | 20.32M | 48.29% |
| Dec 31, 2024 | 42.07M | 5.54M | 15.17% |
| Dec 31, 2023 | 36.53M | 11.67M | 46.93% |
| Dec 31, 2022 | 24.86M | -12.18M | -32.89% |
| Dec 31, 2021 | 37.04M | 29.39M | 383.83% |
| Dec 31, 2020 | 7.66M | -16.99M | -68.94% |
| Dec 31, 2019 | 24.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Travere Therapeutics | 490.73M |
| Arcutis Biotherapeutics | 376.07M |
| Arcus Biosciences | 247.00M |
| IDEAYA Biosciences | 218.71M |
| Soleno Therapeutics | 190.41M |
| Beam Therapeutics | 139.74M |
| Alumis | 24.05M |
| Relay Therapeutics | 15.36M |
TNGX News
- 3 months ago - Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor - GlobeNewsWire
- 3 months ago - Tango Therapeutics Appoints Sung Lee to Board of Directors - GlobeNewsWire
- 4 months ago - Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 6 months ago - Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement - Benzinga
- 6 months ago - Tango Therapeutics Announces $225 Million Financing - GlobeNewsWire
- 6 months ago - Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025 - GlobeNewsWire
- 8 months ago - Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference - GlobeNewsWire